Currently out of the existing stock ratings of Jonathan Wolleben, 341 are a BUY (99.71%), 1 are a HOLD (0.29%).

Jonathan Wolleben

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Wolleben, has had 37.65% of price targets met with an average potential upside of 48.95%, reached in 200 days on average.

Jonathan Wolleben has documented 663 price targets and ratings displayed on 24 stocks. The coverage was on Healthcare, Communication Services sectors.

Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 04-Nov-2026.

Wall Street Analyst Jonathan Wolleben

Analyst best performing recommendations are on DBVT (DBV TECHNOLOGIES).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) on 7/2/2025. The price target of $84 was fulfilled within 7 days with a profit of $17.08 (25.52%), with a performance score of 36.46.

Average potential price target upside

ALT Altimmune CLSD Clearside Biomedical CRNX Crinetics Pharmaceuticals DBVT DBV Technologies LRMR Larimar Therapeutics OCUL Ocular Therapeutix PRQR ProQR Therapeutics BV BCRX BioCryst Pharmaceuticals RLYB Rallybio Corp PHVS Pharvaris BV MDGL Madrigal Pharmaceuticals AURA Aura Biosciences PTGX Protagonist Therapeutics ALLK Allakos MIRM Mirum Pharmaceuticals SPRB Spruce Biosciences RYTM Rhythm Pharmaceuticals SVRA Savara GPCR Structure Therapeutics SGMT Sagimet Biosciences ATXS Astria Therapeutics KALV Kalvista Pharmaceuticals SKYE Skye Bioscience SPOT Spotify Technology SA

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2020

$11

$9.39 (583.23%)

$11

5 months 16 days ago
(02-Jun-2026)

0/19 (0%)

$8.1 (279.31%)

Buy Since 02-Jun-2021

$20

$18.39 (1142.24%)

$17.33

5 months 30 days ago
(19-May-2026)

0/24 (0%)

$17.26 (629.93%)

Buy Since 29-Dec-2021

$28

$26.39 (1639.13%)

$35

7 months 22 days ago
(27-Mar-2026)

0/5 (0%)

$24.98 (827.15%)

Buy Since 25-Sep-2020

$18

$20

1 years 3 months 5 days ago
(13-Aug-2025)

3/14 (21.43%)

$14.26 (381.28%)

272

Buy Since 12-Nov-2024

$24

$26

1 years 3 months 5 days ago
(13-Aug-2025)

0/3 (0%)

$20.26 (541.71%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Jonathan Wolleben most bullish on?

Potential upside of $309.61 has been obtained for MDGL (MADRIGAL PHARMACEUTICALS)

Which stock is Jonathan Wolleben most reserved on?

Potential downside of $6.59 has been obtained for PRQR (PROQR THERAPEUTICS BV)
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?